Correlation Between Valneva SE and Galectin Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Valneva SE and Galectin Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valneva SE and Galectin Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Valneva SE ADR and Galectin Therapeutics, you can compare the effects of market volatilities on Valneva SE and Galectin Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valneva SE with a short position of Galectin Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valneva SE and Galectin Therapeutics.

Diversification Opportunities for Valneva SE and Galectin Therapeutics

-0.41
  Correlation Coefficient

Very good diversification

The 3 months correlation between Valneva and Galectin is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Valneva SE ADR and Galectin Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Galectin Therapeutics and Valneva SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valneva SE ADR are associated (or correlated) with Galectin Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Galectin Therapeutics has no effect on the direction of Valneva SE i.e., Valneva SE and Galectin Therapeutics go up and down completely randomly.

Pair Corralation between Valneva SE and Galectin Therapeutics

Given the investment horizon of 90 days Valneva SE ADR is expected to under-perform the Galectin Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Valneva SE ADR is 1.06 times less risky than Galectin Therapeutics. The stock trades about -0.35 of its potential returns per unit of risk. The Galectin Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  275.00  in Galectin Therapeutics on August 30, 2024 and sell it today you would earn a total of  9.00  from holding Galectin Therapeutics or generate 3.27% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Valneva SE ADR  vs.  Galectin Therapeutics

 Performance 
       Timeline  
Valneva SE ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Valneva SE ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Galectin Therapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Galectin Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting essential indicators, Galectin Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Valneva SE and Galectin Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Valneva SE and Galectin Therapeutics

The main advantage of trading using opposite Valneva SE and Galectin Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valneva SE position performs unexpectedly, Galectin Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Galectin Therapeutics will offset losses from the drop in Galectin Therapeutics' long position.
The idea behind Valneva SE ADR and Galectin Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios